Publications

Fin-Sagas Logo

FIN - SAGAS – Publications

A Peer reviewed articles
B Book chapters
C Presentations

A Peer reviewed articles

2018

Hanisch F, Toresson L, Spillmann T. Cobalamin deficiency in dogs and cats (German). Tierarztl Prax Ausg K, accepted
Ortín-Piqueras V, Spillmann T, Pöytäkangas M, Vaccaro DE, Sankari S, Frías R. Determination of iohexol in canine plasma – strong correlation between enzyme-linked immunosorbent assay, high performance liquid chromatography, and neutron activation analysis. Scandinavian Journal of Laboratory Animal Science 2018: 44 (4)
Kähkönen T, Reunanen V Spillmann T. Canine pancreatitis – review (Finnish). Suomen Eläinlääkärilehti /Finnish Veterinary Journal, 124 (3); 127-35.
Candido MV, Syrjä P, Kilpinen S, Spillmann T. Canine breeds associated with gastric carcinoma, metaplasia and dysplasia diagnosed by histopathology of endoscopic biopsy samples. Acta Vet Scand. 2018 Jun 18;60(1):37. doi: 10.1186/s13028-018-0392-6.
Hanifeh M, Sankari S, Rajamäki MM, Syrjä P, Kilpinen S, Suchodolski JS, Heilmann RM, Guadiano P, Lidbury J, Steiner JM, Spillmann T. S100A12 concentrations and myeloperoxidase activities are increased in the intestinal mucosa of dogs with chronic enteropathies. BMC Vet Res. 2018 Apr 4;14(1):125. doi: 10.1186/s12917-018-1441-0.
Hanifeh M, Rajamäki MM, Syrjä P, Mäkitalo L, Kilpinen S, Spillmann T. Identification of matrix metalloproteinase-2 and -9 activities within the intestinal mucosa of dogs with chronic enteropathies. Acta Vet Scand. 2018 Mar 12;60(1):16. doi: 10.1186/s13028-018-0371-y.
Toresson L, Steiner JM, Razdan P, Spodsberg E, Olmedal G, Suchodolski JS, Spillmann T. Comparison of efficacy of oral and parenteral cobalamin supplementation in normalising low cobalamin concentrations in dogs: A randomised controlled study. Vet J. 2018 Feb;232:27-32. doi: 10.1016/j.tvjl.2017.12.010. Epub 2017 Dec 13.

2017
Toresson L, Steiner JM, Olmedal G, Larsen M, Suchodolski JS, Spillmann T. Oral cobalamin supplementation in cats with hypocobalaminaemia: a retrospective study. J Feline Med Surg. 2017.
Dyggve H, Meri S, Spillmann T, Jarva H, Speeti M. Autoantibodies against histones in Doberman hepatitis – a prospective case-control study. J Vet Intern Med. 2017 Sep 30. doi: 10.1111/jvim.14838.
Forsgård RA, Marrachelli VG, Korpela K, Frias R, Collado MC, Korpela R, Monleon D, Spillmann T, Österlund P. Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague-Dawley rats. Cancer Chemother Pharmacol. 2017 Aug;80(2):317-332.
Dyggve HE, Jarva HK, Spillmann T, Speeti M, Meri SK. Identification of glyceraldehyde-3-phosphate and alcohole dehydrogenases as autoantigens in Doberman Hepatitis. Scandinavian Journal of Immunology, 86 (3), September 2017, 156–64
Gordin, EUM, Syrjä PES, Spillmann T. Feline neutrophilic and lymphocytic cholangitis – review (Finnish). Suomen Eläinlääkärilehti /Finnish Veterinary Journal, 123 (4); 203-10
Turpeinen M, Salonen H, Spillmann T. Feline pancreatitis – review (Finnish), Suomen Eläinlääkärilehti/Finnish Veterinary Journal, 123 (6), 323-31

2016
Westermarck E. Chronic diarrhea in dogs: what do we actually know about it? Top Companion Anim Med. 2016 Jun:31(2):78-84
Kalliokoski S, Piqueras VO, Frías R, Sulic AM, Määttä JA, Kähkönen N, Viiri K, Huhtala H, Pasternack A, Laurila K, Sblattero D, Korponay-Szabó IR, Mäki M, Caja S, Kaukinen K, Lindfors K. Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice. Amino Acids. 2017 Mar;49(3):529-540.
Forsgård RA, Korpela R, Holma R, Lindén J, Frias R, Spillmann T, Österlund P. Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in Sprague-Dawley rats. Cancer Chemother Pharmacol. 2016 Oct:78(4):863-74.
Kasiraj AC, Harmoinen J, Isaiah A, Westermarck E, Steiner JM, Spillmann T, Suchodolski JS. The effects of feeding and withholding food on the canine small intestinal microbiota. FEMS Microbiol Ecol. 2016 Jun;92(6):fiw085.
Grobelna AP, Honkavaara J, Restitutti F, Huuskonen V, Sakka SG, Spillmann T. Evaluation of a transcutaneous method to assess canine liver function by indocyanine green plasma disappearance rate in healthy adult Beagle dogs. Vet J. 2016 Mar;209:169-73.
Toresson L, Steiner JM, Suchodolski JS, Spillmann T. Oral Cobalamin Supplementation in Dogs with Chronic Enteropathies and Hypocobalaminemia. J Vet Intern Med. 2016 Jan-Feb;30(1):101-7.

2015
Hanifeh M, Heilmann RM, Sankari S, Rajamäki MM, Mäkitalo L, Syrjä P, Kilpinen S, Suchodolski JS, Steiner JM, Spillmann T. S100A12 concentrations and myeloperoxidase activity in the intestinal mucosa of healthy dogs. BMC Vet Res. 2015 Sep 14;11:234.
Kilpinen S, Rantala M, Spillmann T, Björkroth J, Westermarck E. Oral tylosin administration is associated with an increase of faecal enterococci and lactic acid bacteria in dogs with tylosin-responsive diarrhoea. Vet J. 2015 Sep;205(3):369-74.
Kainulainen V, Tang Y, Spillmann T, Kilpinen S, Reunanen J, Saris PE, Satokari R. The canine isolate Lactobacillus acidophilus LAB20 adheres to intestinal epithelium and attenuates LPS-induced IL-8 secretion of enterocytes in vitro. BMC Microbiol. 2015 Jan 16;15:4.

2014
Kilpinen S, Spillmann T, Westermarck EEfficacy of two low-dose oral tylosin regimens in controlling the relapse of diarrhea in dogs with tylosin-responsive diarrhea: a prospective, single-blinded, two-arm parallel, clinical field trial. Acta Vet Scand. 2014 Aug 6;56:43.
Hanifeh M, Rajamäki MM, Mäkitalo L, Syrjä P, Sankari S, Kilpinen S, Spillmann T. Identification of matrix metalloproteinase-2 and -9 activities within intestinal mucosa of clinically healthy beagle dogs. J Vet Med Sci. 2014 Aug;76(8):1079-85. Epub 2014 Apr 18.
Spillmann T, Willard MD, Ruhnke I, Suchodolski JS, Steiner JM. Feasibility of endoscopic retrograde cholangiopancreatography in healthy cats. Vet Radiol Ultrasound. 2014 Jan-Feb;55(1):85-91. doi: 10.1111/vru.12086. Epub 2013 Aug 6.
Frias R, Ouwehand AC, Jaakkold , U-M, Spillmann T, Gueimonde M. An in vivo permeability test protocol using iohexol to reduce and refine the use of laboratory rats in intestinal damage assessment , Scandinavian Journal of Laboratory Animal Science 2014, 40 (1):1-6

2013
Hang I, Heilmann RM, Grützner N, Suchodolski JS, Steiner JM, Atroshi F, Sankari S, Kettunen A, de Vos WM, Zentek J, Spillmann T. Impact of diets with a high content of greaves-meal protein or carbohydrates on faecal characteristics, volatile fatty acids and faecal calprotectin concentrations in healthy dogs. BMC Vet Res. 2013 Oct 9;9:201.
Grützner N, Hang I, Heilmann RM, Spillmann T, Suchodolski JS, Steiner JM. Analytical validation of radioimmunoassays for the quantification of select pancreatic enzymes in jejunal fluid and fecal extracts from dogs. Vet J. 2013 Oct;198(1):200-5. doi: 10.1016/j.tvjl.2013.07.022. Epub 2013 Aug 15.

2012
Hang I, Rinttila T, Zentek J, Kettunen A, Alaja S, Apajalahti J, Harmoinen J, de Vos WM, Spillmann T. Effect of high contents of dietary animal-derived protein or carbohydrates on canine faecal microbiota. BMC Vet Res. 2012 Jun 26;8:90.
Alander JT, Kaartinen I, Laakso A, Pätilä T, Spillmann T, Tuchin VV, Venermo M, Välisuo P. A review of indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging. 2012;2012:940585. doi: 10.1155/2012/940585. Epub 2012 Apr 22.
Frias R, Strube K, Ternes W, Collado MC, Spillmann T, Sankari S, Westermarck E. Comparison of 51chromium-labeled ethylenediamine tetra-acetic acid and iohexol as blood markers for intestinal permeability testing in Beagle dogs. Vet J. 2012 Apr;192(1):123-5. doi: 10.1016/j.tvjl.2011.04.024. Epub 2011 Jun 8.
Frias R, Steiner JM, Williams DA, Sankari S, Westermarck E. Urinary recovery of orally administered chromium 51-labeled EDTA, lactulose, rhamnose, d-xylose, 3-O-methyl-d-glucose, and sucrose in healthy adult male Beagles. Am J Vet Res. 2012 May;73(5):654-8.

2011
Dyggve H, Meri S, Spillmann T, Lohi H, Kennedy LJ, Speeti M. Evaluation of DLA promoters in Doberman hepatitis. Tissue Antigens. 2011 Dec;78(6):446-50.
Kilpinen S, Spillmann T, Syrjä P, Skrzypczak T, Louhelainen M, Westermarck E. Effect of tylosin on dogs with suspected tylosin-responsive diarrhea: a placebo-controlled, randomized, double-blinded, prospective clinical trial. Acta Vet Scand. 2011 Apr 14;53:26.
Frias R, Harmoinen J, Laitinen-Vapaavuori O, Spillmann T, Sankari S, Westermarck E. Small intestinal permeability and serum folate and cobalamin absorption after surgical construction of permanent jejunal fistulas in laboratory beagle dogs. Comp Med. 2010 Oct;60(5):369-73.
Dyggve H, Kennedy LJ, Meri S, Spillmann T, Lohi H, Speeti M.  Association of Doberman hepatitis to canine major histocompatibility complex II. Tissue Antigens. 2011 Jan;77(1):30-5. Epub 2010 Oct 12.

2010
Frias R, Collado MC, Spillmann T, Sankari S, Westermarck E. The 51-chromium-labeled ethylenediamine tetra-acetic acid intestinal permeability blood test in healthy Beagle dogs: a comparison between serum and plasma levels. J Vet Diagn Invest. 2010 Nov;22(6):949-53.

2009
Pápa K, Psáder R, Sterczer A, Pap A, Rinkinen M, Spillmann T. Endoscopically guided nasojejunal tube placement in dogs for short-term postduodenal feeding. J Vet Emerg Crit Care (San Antonio). 2009 Dec;19(6):554-63.
Suchodolski JS, Dowd SE, Westermarck E, Steiner JM, Wolcott RD, Spillmann T, Harmoinen JA. The effect of the macrolide antibiotic tylosin on microbial diversity in the canine small intestine as demonstrated by massive parallel 16S rRNA gene sequencing. BMC Microbiol. 2009 Oct 2;9:210.
Klenner S, Frias R, Coenen M, Failing K, Hewicker-Trautwein M, Ternes W, Verspohl J, Spillmann T. Estimation of intestinal permeability in healthy dogs using the contrast medium iohexol. Vet Clin Pathol. 2009 Sep;38(3):353-60. Epub 2009 Mar 30.

2005
Spillmann T, Schnell-Kretschmer H, Dick M, Gröndahl KA, Lenhard TC, Rüst SK. Endoscopic retrograde cholangio-pancreatography in dogs with chronic gastrointestinal problems. Vet Radiol Ultrasound. 2005 Jul-Aug;46(4):293-9.
Spillmann T, Happonen I, Kähkönen T, Fyhr T, Westermarck E. Endoscopic retrograde cholangio-pancreatography in healthy Beagles. Vet Radiol Ultrasound. 2005 Mar-Apr;46(2):97-104.
Spillmann T, Happonen I, Sankari S, Wittker A, Kähkönen T, Westermarck E. Evaluation of serum values of pancreatic enzymes after endoscopic retrograde pancreatography in dogs. Am J Vet Res. 2004 May;65(5):616-9.

B Book Chapters in Veterinary Text Books

2017
Spillmann T. Pancreatitis – Etiology and Pathophysiology. In Ettinger SJ, Feldman EC, Cote E (eds): Textbook of Veterinary Internal Medicine, 8th ed. WB Saunders/Elsevier, St Louis, Missouri, USA 2016: 1681-2

2014
Wiberg M. Exocrine pancreatic insufficiency in dogs. In: Bonagura J. & Twedt D. (eds.): Kirk Current Veterinary Therapy XV. St Louis, Missouri: Elsevier Saunders 2014: 558-60

2013
Spillmann, T. Intestinal endoscopy. In: Washabau, R. J. & Day, M. J. (eds.) Canine and Feline Gastroenterology. WB Saunders/Elsevier, St. Louis, Missouri, USA 2013: 282-7
Spillmann, T. Laparoscopy pancreas. In: Washabau R J. Gastrointestinal and Liver diseases in the dog and cat. WB Saunders/Elsevier, St. Louis, Missouri, USA 2013: 327-31
Spillmann, T. Autio, K. Tumoren des exokrinen Pankreas. In: Kleintieronkologie: Diagnose und Therapie von Tumorerkrankungen bei Hund und Katze. Kessler, M. (ed.). 3. ed. Enke, Stuttgart, Germany 2013: 342-4
Westermarck E. Enzyme Supplementation. In: Washabau R J. Gastrointestinal and Liver diseases in the dog and cat. WB Saunders/Elsevier, St. Louis, Missouri, USA 2013: 512-3
Westermarck E. Breed related diseases - Pancreas. In: Washabau R J. Gastrointestinal and Liver diseases in the dog and cat. WB Saunders/Elsevier, St. Louis, Missouri, USA 2013: 965-6
Wiberg M. Pancreas - Insufficiency. In: Washabau R J. Gastrointestinal and Liver diseases in the dog and cat. WB Saunders/Elsevier, St. Louis, Missouri, USA 2013:834-8

2009
Spillmann, T. Melaena und Hämatochezie. In Neiger R. Differenzialdiagnosen innere Medizin bei Hund und Katze. Enke, Stuttgart, Germany 2009: 291-299
Westermarck E. Tylosin-responsive diarrhea. In: Bonagura JD, Twedt DC. Kirk’s Current Veterinary Therapy XIV, Saunders Elsevier, St. Louis, 2009: 506-8
Wiberg ME. Exocrine pancreatic insufficiency in dogs. In: Bonagura JD, Twedt DC. Kirk’s Current Veterinary Therapy XIV, Saunders Elsevier, St. Louis, 2009: 531-3

2008
Westermarck E. Clinical evaluation of patients with chronic diarrhea. In: Steiner JM. Small Animal Gastroenterology. Schlütersche, Hannover, 2008: 127-33

2005
Spillmann T. Endoskopie des Verdauungsapparates. In: Grünbaum E-G, Schimke E. Klinik der Hundekrankheiten, 3. Auflage, Enke, Stuttgart, Germany 2007, 67-69
Spillmann T. Klinische Untersuchung der Verdauungsorgane. In: Grünbaum E-G, Schimke E. Klinik der Hundekrankheiten, 3. Auflage, Enke, Stuttgart, Germany 2007, 452-455
Spillmann T. Endoskopische Untersuchungsmethoden In: Grünbaum E-G, Schimke E. Klinik der Hundekrankheiten, 3. Auflage, Enke, Stuttgart, Germany 2007, 456-458
Spillmann T. Erkrankungen der Verdauungsorgane (konservativ). In: Grünbaum E-G, Schimke E. Klinik der Hundekrankheiten, 3. Auflage, Enke, Stuttgart, Germany 2007, 463-502
Spillmann T. Leber und exokrines Pankreas. In: Grünbaum E-G, Schimke E. Klinik der Hundekrankheiten, 3. Auflage, Enke, Stuttgart, Germany 2007, 502-531
Westermarck E, Wiberg M, Steiner JM, Williams DA. Exocrine pancreatic insufficiency in dogs and cats. In: Ettinger SJ, Feldman EC. Textbook of Veterinary Internal medicine. 6th ed., Saunders Elsevier, St. Louis, 2005: 1492-6

C Presentations

2018
Honneffer JB, Toresson L, Guard B, Wennogle S, Jergens AE, Lidbury JA, Steiner JM, Suchodolski S. Increased Fecal Fatty Acid Concentrations in Dogs with Chronic Enteropathy Normalize with Treatment. ACVIM Forum 13-16/6 2018, Seattle, Washington
Toresson L. Cobalamin supplementation improves CIBDAI in dogs with low cobalamin concentrations. Eurogut meeting, 11-13/52018, Rome, Italy

2017
Hanifeh M, Sankari S, Rajamäki MM, Syrjä P, Kilpinen S, Suchodolski JS, Guadiano P, Lidbury J, Steiner JM, Spillmann T. S100A12 and myeloperoxidase as possible biomarkers for intestinal inflammation in dogs. 27th ECVIM-CA Congress, St. Julians, Malta, 14.-16.9.2017
Forsgård RA, Marrachelli VG, Korpela K, Holma R, Lindén J, Frias R, Collado MC, Korpela R, Monleon D, Spillmann T, Österlund P. Chemotherapy-induced gastrointestinal toxicity is associated with changes in intestinal permeability, fecal microbiota, and the metabolome in Sprague-Dawley rats [Abstract]. III International Symposium on Profiling - ISPROF 2017. Lisbon, Portugal, 4.-7.9.2017.
Toresson L, Steiner JM, Suchodolski JS, Spillmann T. Oral Cobalamin Supplementation in Dogs with Exocrine Pancreatic Insufficiency. 2017 ACVIM Forum, Washington, Maryland, USA, 7-10.6.2017
Candido MV. Clinical application of chromoendoscopy and narrow band imaging to GI diseases. EuroGut – ESCG Spring Meeting, Vienna, Austria, 13-14.5.2017
Dyggve H. Doberman hepatitis- evidence for an autoimmune background. EuroGut – ESCG Spring Meeting, Vienna, Austria, 13-14.5.2017
Hanifeh M. Matrix metalloproteinase (MMP) 2 and 9 as possible biomarkers for intestinal inflammation in dogs. EuroGut – ESCG Spring Meeting, Vienna, Austria, 13-14.5.2017
Spillmann T. First experiences in ERCP guided sphincterotomy of the major papilla in dogs and cats. EuroGut – ESCG Spring Meeting, Vienna, Austria, 13-14.5.2017
Candido MV. Clinical application of chromoendoscopy and narrow band imaging to gastrointestinal diseases. Inter -University Exchange Seminar Hokkaido University – University of Helsinki, Helsinki, Finland, 2-3.4.2017
Dyggve H. Dobermann hepatitis – a canine model for autoimmune hepatitis in humans? Inter -University Exchange Seminar Hokkaido University – University of Helsinki, Helsinki, Finland, 2-3.4.2017
Spillmann T. Clinical application of endoscopic retrograde cholangiography in dogs and cats. Inter -University Exchange Seminar Hokkaido University – University of Helsinki, Helsinki, Finland, 2-3.4.2017

 

2016
Forsgård RA, Korpela R, Holma R, Lindén J, Frias R, Spillmann T, Österlund P., Chemotherapy-induced gastrointestinal toxicity is associated with increased intestinal permeability to iohexol in Sprague-Dawley rats [Abstract]. Gastro 2016 – EGHS-WGO International Congress. Abu Dhabi, United Arab Emirates, 17-19.11.2016
Kilpinen S. Tylosin-responsive diarrhoea in dogs. (Invited scientific lecture) 26th ECVIM-CA Congress, Gothenburg, Sweden, 8.-10.9.2016
Candido M, Syrjä P, Kilpinen S, Spillmann T.Breed association of endoscopically diagnosed gastric neoplasia and metaplasia in purebred dogs – a retrospective study. 26th ECVIM-CA Congress, Gothenburg, Sweden, 8.-10.9.2016
Grobelna AP, Honkavaara J, Restitutti F, Kallio-Kujala I, Sakka SG, Spillmann T. Real-time assessment of canine liver function: variation of transcutaneous determined indocyanine green plasma disappearance rate (ICG-PDR) in healthy dogs. 26th ECVIM-CA Congress, Gothenburg, Sweden, 8.-10.9.2016
Ortin Piqueras V, Spillmann T, Pöytäkangas M, Sankari S, Frias R. Validation of an enzyme-linked immunosorbent assay for measuring iohexol in canine serum as a marker for intestinal permeability and glomerular filtration rate. 26th ECVIM-CA Congress, Gothenburg, Sweden, 8.-10.9.2016
Toresson L, Steiner JM, Suchodolski JS, Spillmann T. Methylmalonic acid concentrations in dogs with hypocobalaminemia treated with oral versus parenteral cobalamin supplementation. 26th ECVIM-CA Congress, Gothenburg, Sweden, 8.-10.9.2016
Toresson L, Steiner JM, Suchodolski JS, Spillmann T. Oral versus parenteral cobalamin supplementation in dogs with chronic enteropathies and hypocobalaminemia. 2016 ACVIM CA Forum, Denver CO, USA, 8.-11.6.2016

2015
Ortin Piqueras V, Spillmann T, Pöytäkangas M, Honkavaara JM, Sankari S, Vaccaro DE, Frias R. Measurement of iohexol from canine plasma: comparative analysis between enzyme-linked immunosorbent assay, neutron activation analysis and high performance liquid chromatography. Scand-LAS 2015, Turku, Finland, 9.-12.6.2015
Ortin Piqueras V, Koskinen M, Hewetson M, Spillmann T, Pöytäkangas M, Honkavaara JM, Sankari S, Vaccaro DE, Frias R. Measurement of iohexol from equine plasma: comparative analysis between enzyme-linked immunosorbent assay and high performance liquid chromatography. Scand-LAS 2015, Turku, Finland, 9.-12.6.2015
Toresson L, Steiner JM, Göransson M, Elmgren L, Suchodolski JS, Spillmann T. Oral cobalamin supplementation in cats with hypocobalaminemia. 25th ECVIM-CA Congress, Lisbon, Portugal. 2015

2014
Toresson L, Steiner JM, Suchodolski JS, Spillmann T. Oral cobalamin supplementation in dogs with chronic enteropathies and hypocobalaminemia. 2014 ACVIM Forum, Nashville, Tennessee, USA, 04.–07.06.2014
Hanifeh M, Rajamäki MM, Mäkitalo L, Sankari S, Syrjä P, Spillmann T. Characterization of matrix metalloproteinase-2 and -9 in different parts of intestinal mucosa of healthy beagle dogs. 24th ECVIM-CA Congress, Mainz, Germany, 4.-6.9.2014
Hanifeh M, Heilmann RM, Sankari S, Rajamäki MM, Mäkitalo L, Syrjä P, Kilpinen S, Suchodolski JS, Steiner JM, Spillmann T. Determination of S100A12 and myeloperoxidase levels within intestinal mucosa of clinically healthy beagle dogs. 24th ECVIM-CA Congress, Mainz, Germany, 4.-6.9.2014

2013
Suchodolski JS, Dowd SE, Westermarck E, Steiner JM, Spillmann T, Harmoinen JA. The effect of food withholding on the canine small intestinal microbiota. 2013 ACVIM Forum, Seattle, WA, USA, 12.-15.06.2013

2012
Dyggve H, Meri S, Spillmann T, Jarva H, Speeti M. Anti-histone antibodies in Doberman hepatitis. 22nd ECVIM-CA Congress, Maastricht, Netherlands, 06.-08.09.2012
Hanifeh M, Sankari S, Rajamäki MM, Atroshi F, Mäkitalo L, Syrjä P, Spillmann T. Analytical validation of a method for quantitative determination of myeloperoxidase (MPO) in different parts of intestinal mucosa from healthy laboratory beagle dogs. 22nd ECVIM-CA Congress, Maastricht, Netherlands, 06.-08.09.2012
Spillmann T, Frias R. Assessment of intestinal permeability in dogs. Nestle Purina Companion Animal Nutrition Summit, Lisbon, Portugal, 22.-24.03.2012

2011
Spillmann T, Willard MD, Ruhnke I, Suchodolski J, Steiner JM. Endoscopic retrograde cholangiopancreatography (ERCP) in healthy cats – a feasibility study. 21st ECVIM-CA Congress, Seville, Spain, 08.-10.9.2011
Dyggve H, Meri S, Spillmann T, Jarva H, Speeti M. Anti-nuclear antibodies in Doberman hepatitis. 21st ECVIM-CA Congress, Seville, Spain, 08.-10.9.2011
Kilpinen S, Rantala M, Spillmann T, Björkroth J, Westermarck E. Tylosin administration increases the levels of Enterococcus spp. in the feces of dogs with tylosin-responsive diarrhea. 21st ECVIM-CA Congress, Seville, Spain, 08.-10.9.2011

2010
Dyggve H, Kennedy LJ, Meri S, Ahonen S, Speeti M..Evaluation of promoter alleles and exon 2 of dla-dqb1, -dqa1 and -drb1 in Dobermans with and without hepatitis. 2010 ACVIM Forum, Anaheim, CA, USA, June 9-12, 2010
Mõistus I; de Vos WM, Zentek J; Harmoinen J; Kettunen A; Rinttila T; Apajalahti J, Spillmann T. Effect of excess dietary protein and carbohydrate on the intestinal microbiota in healthy beagles as analyzed by guanine-plus-cytosine-based profiling. 2010 ACVIM Forum, Anaheim, CA, USA, June 9-12, 2010
Grützner N, Mõistus I, Suchodolski JS, Spillmann T, Steiner JM. Analytical validation of a radioimmunoassay for the measurement of canine pancreatic lipase immunoreactivity in chyme and fecal extracts from dogs. 2010 ACVIM Forum, Anaheim, CA, USA, June 9-12, 2010
Kilpinen S, Spillmann T, Westermarck E. Determination of the dosage regimen of tylosin in the treatment of canine tylosin-responsive diarrhea. 2010 ACVIM Forum, Anaheim, CA, USA, June 9-12, 2010
Dyggve H, Jarva H, Spillmann T, Meri S, Speeti M. Autoantibodies in Doberman hepatitis. 20th ECVIM-CA Congress, Toulouse, France, 9.-11.9.2010

2009
Kilpinen S, Spillmann T, Syrjä P, Skrypczak T, Westermarck E. Effect of tylosin on dogs with diarrhea: A placebo-controlled, randomized, double-blinded, prospective clinical trial. 19th ECVIM-CA Congress, Porto, Portugal, 8.-10.09.2009: 249
Moistus I, Sankari S, Zentek J, Spillmann T. Dietary protein and carbohydrate affect metabolism of intestinal microbiota in healthy dogs. 19th ECVIM-CA Congress, Porto, Portugal, 8.-10.09.2009: 248
Suchodolski JS, Down SE, Steiner JM, Westermarck E, Spillmann T, Harmoinen JA. The effect of tylosin on small intestinal microbiota in healthy dogs. 19th ECVIM-CA Congress, Porto, Portugal, 8.-10.09.2009: 213
Grützner N, Moistus I, Suchodolski JS, Spillmann T, Steiner JM. Analytical validation of a radioimmunoassay for the quantification of canine trypsin-like immunoreactivity for use in chime and fecal samples from dogs. 19th ECVIM-CA Congress, Porto, Portugal, 8.-10.09.2009:248
Dyggve H, Kennedy LJ, Meri S, Spillmann T, Lohi H, Speeti M. Linkage of Doberman hepatitis to the canine major histocompatibility complex. 19th ECVIM-CA Congress, Porto, Portugal, 8.-10.09.2009: 236-237
Bochko V, Luukkainen-SoiluM, Välisuo P, Peltoniemi OAT, Rosenberg PH, Sukura AK, Syrjä P, Spillmann T, Alander J. Functional data analysis for endoscopic spectral measurements. Satarow Fall Meeting, Russia, 21. – 24.09. 2009

2008
Klenner S, Ternes W, Failing K, Frias R, Spillmann T. Assessment of intestinal permeability using iohexol in healthy dogs. Abstract, 16. Jahrestagung der Fachgruppe „Innere Medizin und Klinische Labordiagnostik“ der DVG, 2.-3.02.2008, Giessen, Germany

2007
Papa K, Psader R, Sterczer A, Pap A, Rinkinen M, Spillmann T. Endoscopically guided nasojejunal tube placement in dogs for short term postduodenal feeding. Poster, 17th ECVIM-CA Congress, Budapest, 13.-15.09.2007: 233
Frias R, Harmoinen J, Spillmann T, Sankari S, Westermarck E. Permanent jejunal fistulas do not affect the small intestinal absorption or permeability in Beagle dogs. Poster, 10th FELASA/ICLAS, Italy, 11.-14. 06. 2007

2006
Suchodolski JS, Harmoinen JA, Westermarck E, Williams DA, Spillmann T, Steiner JM. Effect of Tylosin on the Qualitative and Quantitative Composition of the Jejunal Microflora. ACVIM Forum Charlotte, 2006
Harmoinen J, Björkroth J, Spillmann T, Westermarck E. Effect of Tylosin on the Qualitative Composition of Canine Jejunal Microbiota, 31st World Congress of the WSAVA, Prague, Czech Republic, 2006

2005
Frias R, Strube K, Bergmann K, Ternes W, Sankari S, Spillmann T, Westermarck E. Comparison of 51Cr-EDTA and iohexol as intestinal permeability markers in dogs. 15th ECVIM-CA Congress, Glasgow, 01.-03.09.2005
Frias R, Sankari S, Spillmann T, Westermarck E. 51Cr-EDTA permeability blood test in dogs can be equally performed in serum or plasma. 15th ECVIM-CA Congress, Glasgow, 01.-03.09.2005
Klenner S, Bergmann K, Hewicker-Trautwein M, Coenen M, Ternes W, Frias R, Spillmann T. Determination of iohexol in canine serum for the assessment of intestinal permeability. 15th ECVIM-CA Congress, Glasgow, 01.-03.09.2005